Neuronet ECR submission for the virtual Alzheimer Europe Conference is open! BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA Dankert BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA Public Newsletter 2020 BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA EMA Public Support for Mobilise-D BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA [VIDEO] Introducing the Mobilise-D Clinical Trials BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA Mobilise-D well represented at the Virtual Physiological Human Conference 2020 BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

About Us

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

About Us

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

About Us

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed

Mobilise-D @Mobilise_D

🔎📖✅We have created a new #MobiliseD Community on @ZENODO_ORG. The goal is to provide #OpenAccess to all our publications!

🔗 https://t.co/0IRHhMghs4

All our publications can be found on our website and @OpenAIRE_eu:
➡️ https://t.co/nE5aKplodv
➡️ https://t.co/zELQGdiVQP
View on Twitter
6
10
Mobilise-D @Mobilise_D

🔵FPFV in Erlangen - #JustDoIt🔴

Well done to our assessors in Erlangen that successfully completed their First Patient First Visit yesterday👏

📷The participant filling out the questionnaires on the magnificent @ERTglobal tablet. He is also part of our #PatientAdvisoryGroup https://t.co/1gjVOTUpWc
View on Twitter
Mobilise_D photo
3
8

Latest News

Neuronet ECR submission for the virtual Alzheimer Europe Conference is open!

Neuronet invites Early Career Researchers from the Innovative Medicines Initiative’s neurodegeneration research projects to present their work at the upcoming Alzheimer Europe Conference.Applicants whose abstracts are accepted for a Quick Oral or Poster presentation will be granted a free registration to attend the three-day virtual conference. The deadline for submissions is June 30. This will…

Read more

Upcoming Events

No event found!
Sign up for our Newsletter!